NOVEL AMINO ACID DERIVATIVES

Pharmaceutical Composition, Methods of Use Thereof for Treating Cocaine Addiction, and Novel Use of Hausp K444R Point Mutant Mouse

ARYLSULFONAMIDES AS OREXIN RECEPTOR AGONISTS

Compounds as NLRP3 inflammasome inhibitors and compositions and uses thereof

Compound used as SIRT6 small-molecule allosteric activator and pharmaceutical composition thereof

INHIBITORS OF KIDNEY-TYPE GLUTAMINASE, GLS-1

Polymorphic forms of Belinostat and processes for preparation thereof

COMPOUNDS, PHARMACEUTICAL COMPOSITION AND THEIR USE IN TREATING NEURODEGENERATIVE DISEASES

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

Inhibitors of kidney-type glutaminase, GLS-1

Energy providing devices and applications thereof

Polymorphic forms of belinostat and processes for preparation thereof

Compounds and compositions for treating conditions associated with NLRP activity

Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

SUBSTITUTED 3-HALOALLYLAMINE INHIBITORS OF SSAO AND USES THEREOF

ROR-gamma modulators and uses thereof

Polymerizable sulfonamide compounds and polymers thereof

Energy providing devices and applications thereof

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

Substituted 3-haloallylamine inhibitors of SSAO and uses thereof

Fluorescent pI Markers for Isoelectric Focusing Separations and Fluorescent Labeling

Sodium channel modulators

Enamine compounds for absorbance of electromagnetic energy

Inhibitors of kidney-type glutaminase, GLS-1

Ethynylbenzene derivatives

PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITORS AND METHODS OF USE THEREOF

Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof-I

Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases

NITRIFICATION INHIBITORS

Substituted 3-haloallylamine inhibitors of SSAO and uses thereof

Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereof

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors

Cryopyrin inhibitors for preventing and treating inflammation

Sepiapterin reductase inhibitors for the treatment of pain

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS

Enzyme inhibitors

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

Compounds for use in the treatment of mycobacterial infections

Alpha-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEROF-I

Substituted 3-haloallylamine inhibitors of ASSAO and uses thereof

Compounds

Fluorescent pI markers for isoelectric focusing separations and fluorescent labeling

Substituted 4-aminocyclohexane derivatives

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

Screening methods for spinal muscular atrophy

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors

Thiol mediated/activated prodrugs of sulfur dioxide (SO) having anti-bacterial activity

NOVEL PHARMACEUTICAL FORMS, AND METHODS OF MAKING AND USING THE SAME

Ethynylbenzene derivatives

ACYLSULFONAMIDES AND PROCESSES FOR PRODUCING THE SAME

Substituted 4-aminocyclohexane derivatives

Biaryl oxyacetic acid compounds

Cathepsin cysteine protease inhibitors

Sepiapterin reductase inhibitors for the treatment of pain

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

Substituted 4-aminocyclohexane derivatives

Indane derivatives

Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support

Compositions and methods for the treatment of disease associated with TRP-P8 expression

Pharmaceutical forms, and methods of making and using the same

Cathepsin cysteine protease inhibitors

Cyclohexane derivatives and uses thereof

Cyclic hydrocarbon compounds for the treatment of diseases

CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASE

Thyroid receptor ligands

Amine derivatives having NPY Y5 receptor antagonistic activity and the uses thereof

Process for preparing tamsulosin hydrochloride

Amine derivative having NPY Y5 receptor antagonistic activity

Biaryl carboxylic acid apoptosis promoters

Method for producing optically active amines

BENZENESULFONAMIDE MODULATORS OF ALPHA-1A ADRENERGIC RECEPTORS

SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support

5-[(2R)-[2-[2-(2,2,2-TRIFLUOROETHOXY)PHENOXY]ETHYL]AMINO]PROPYL]-2-METHOXYBENZENESULFONAMIDE

Certain Chemical Entities, Compositions, and Methods

Amine derivative having NPY Y5 receptor antagonistic activity

Imidazopyridinyl benzamide mitotic kinesin inhibitors

Imidazopyridinyl benzamide mitotic kinesin inhibitors

N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

Aryl sulfonamides useful as inhibitors of chemokine receptor activity

SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES

Process for the preparation of tamsulosin and intermediates thereof

PROCESS FOR THE PREPARATION OF TAMSULOSIN AND RELATED COMPOUNDS

Inhibitors of carbonic anhydrase IX

Indene derivatives, their preparation and use as medicaments

Crystallization process

Lysine related derivatives as HIV aspartyl protease inhibitors

Compounds to treat alzheimer's disease

Method of preparation of (R)-(−)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide

Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support

Squaric Acid Derivatives

Process for the Preparation of Tamsulosin

ANTIBACTERIAL AGENTS

Certain chemical entities, compositions, and methods

Calcium receptor modulating agents

Formamide derivatives for the treatment of diseases

Method for Preparing Halogenated Amines

Cathepsin cysteine protease inhibitors

Novel Sulfonamide derivative

Novel Compounds

Process for Manufacturing Optically Pure (R) or (S)-5-(2-Aminopropyl)-2-Methoxybenzene Sulfonamide

Preparation of R-5- (2-(2-Ethoxyphenoxyetylamino) -2-Methoxybenzen-Sulphonamide Hydrochloride of High Chemical

Arylsulfonamidyl tetralin derivatives and uses thereof

N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives

Compounds which potentiate glutamate receptor and uses thereof in medicine

Manufacture of a polymer device

Amorphous tamsulosin hydrochloride

Synthesis of optically pure(r)-5-(2-amynopropyl)-2-methoxybenzenesulphonamide

Amide inhibitors of leukotriene A4 hydrolase

Imidazoyl-benzamide anti-cancer agents

Process for preparing Tamsulosin

Apoptosis promoters

Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity

Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation

5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation

Preventives/remedies for urinary disturbance

N-(2-ARYLETHYL)BENZYLAMINES AS ANTAGONISTS OF THE 5-HT6 RECEPTOR

Process for preparation of tamsulosin and its aralkylamine derivatives

N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases

Inhibitors of cdc25 phosphatases

Compounds for the treatment of Alzheimer's disease

Preventives/remedies for urinary disturbance

5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation

Process for the preparation of enantiomerically pure (r) or (s)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide

Inhibitors of Cdc25 phosphatases

5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation

Imidazopyridinyl-benzamide anti-cancer agents

Process for the resolution of racemic (R,S) -5-(2-(2-(2- ethoxyphenoxy) ethylamino)Propyl)-2-methoxybenzene sulfonamide (tamsulosin), its novel R and S isomers and their salts and processes for their preparation

Preventives/remedies for urinary disturbance

Antibacterial agents

Process for preparing tamsulosin

N-(2-Arylethyl) benzylamines as antagonists of the 5-HTreceptor

Histamine-3 receptor antagonists

Cathepsin cysteine protease inhibitors

Formamide derivatives for the treatment of diseases

Compounds to treat Alzheimer's disease

Preventives/remedies for urinary disturbance

Tamsulosin derivative

Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation

Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support

Agents for the prevention or treatment of renal diseases

Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith

Aryl sulfonamides useful as inhibitors of chemokine receptor activity

Process for preparing R- and S-isomers of (R)-5-(2-( (2-(2-ethoxyphenoxy) ethyl) amino) propyl) -2-methoxybenzenesulfonamide

Compositions and methods for the treatment of disease associated with Trp-p8 expression

Process for the separation of R(-)-and S(+)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2- methoxybenzenesulfonamide

Thyroid receptor ligands